Figure 2

Biocompatibility of EDT-IONPs on b.End3, MDCK-MDR1 and U251 cell lines after 48-h treatment using MTT assay (n = 5). DOX concentration was 1 µg/mL. The Y-axis represents cell viability compared to the control.
Biocompatibility of EDT-IONPs on b.End3, MDCK-MDR1 and U251 cell lines after 48-h treatment using MTT assay (n = 5). DOX concentration was 1 µg/mL. The Y-axis represents cell viability compared to the control.